FDA Approves Rocklatan
DURHAM, N.C.–(BUSINESS WIRE)–Mar. 12, 2019– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the […]
NEW YORK, December 21, 2018 (GLOBE NEWSWIRE) – Stemline Therapeutics, Inc. (NASDAQ:STML), a biopharmaceutical company focused on the development and […] RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food […] THURSDAY, Nov. 8, 2018 — A new version of an over-the-counter asthma inhaler that was taken off the market in […] FRIDAY, Oct. 12, 2018 — The U.S. Food and Drug Administration has approved the ID CORE XT DNA-based test to […] South San Francisco, CA — October 4, 2018 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: […] EWING, N.J., Oct. 01, 2018 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ:ATRS) today announced the approval of Xyosted (testosterone enanthate) […] September 27, 2018 – Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Vizimpro […] BOSTON–(BUSINESS WIRE)–Sep. 24, 2018– Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve […] KENILWORTH, N.J.–(BUSINESS WIRE) August 30, 2018 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today […]approves
FDA Approves Elzonris (tagraxofusp-erzs), the First Treatment for Blastic Plasmacytoid Dendritic Cell Neoplasm and First CD123-Targeted Therapy
FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma
FDA Approves New Version of OTC Primatene Mist
FDA Approves New DNA-Based Test to Verify Blood Compatibility
FDA Approves Genentech’s Hemlibra (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors
FDA Approves Xyosted
FDA Approves Vizimpro
FDA Approves Copiktra
FDA Approves Delstrigo